OTC drug marketing strategy, action first, no more talking.

Published: 2004-10-26 06:57:00

Updated: 2004-10-26 06:57:00

Most of pharmaceutical companies are now trying to review their strategies for the promotion of OTC drug market in which a "talking only" attitude that had been derived from the poor sales outcomes would no longer viable but to put a substantial action right away by exploring diverse reviving pro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK